CERDELGA caps 84 mg 14 pce
7680666960011
CH-66696
A16AX10
07.99.0.
Reimbursement limitations:
CERDELGA
Pour la monothérapie chez les patients adultes atteints d’une maladie de Gaucher de type I …
1 / 3
google
Details
- Product number
- 6669601
- CPT
- -
- Packaging group
- 14
- Unit
- Kapsel(n)
- Composition
- eliglustatum 84.4 mg ut eliglustati tartras 100 mg, cellulosum microcristallinum, lactosum monohydricum 111.5 mg, hypromellosum, glyceroli dibehenas, matériel de la capsule: gelatina, kalii aluminii silicas, E 171, E 172 (flavum), E 132, encre: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula corresp. natrium max. 0.01 mg.
Articles (1)
Cerdelga 84 mg, gélules
Kapseln
14
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
84.4 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
100.0 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
111.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 66696
- Drug name
- Cerdelga, gélules
- Galenic form
- KAHA
- ATC Code
- A16AX10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 19/02/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CERDELGA caps 84 mg 14 pce
- Description (DE)
- CERDELGA Kaps 84 mg 14 Stk
- Market launch
- 19/02/2020
- Narcotic (BTM)
- No